Keita Kawakado
Keita Kawakado publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Cardiology and Cardiovascular Medicine, on topics such as Lung Cancer Treatments and Mutations, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis and Venous Thromboembolism Diagnosis and Management.
- World rank
- #5,746,268 of 7,710,434 ranked researchers
- Rank in Japan
- #204,452 of 383,136
- Works
- 30
- Citations
- 125
- Citations per work
- 4.2
What does Keita Kawakado research?
Keita Kawakado's work is mostly in Medicine (69%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2169.4%
- Medicine2169.4%
- Everything else930.6%
- 1Pulmonary and Respiratory Medicine32% of their works
- 2Oncology18% of their works
- 3Cardiology and Cardiovascular Medicine6% of their works
- 4Physiology5% of their works
- 5Surgery5% of their works
- 6Internal Medicine5% of their works
Research topics
- Lung Cancer Treatments and Mutations
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Venous Thromboembolism Diagnosis and Management
- Cancer Immunotherapy and Biomarkers
- Sarcoidosis and Beryllium Toxicity Research
- Tracheal and airway disorders
- Atrial Fibrillation Management and Outcomes
- Lung Cancer Research Studies
Which keywords describe Keita Kawakado's research?
The keywords of their largest research topics: Clinical Trials, Targeted Therapy, ALK Inhibitors, EGFR Mutations, Diagnosis, Fibrosis, Idiopathic Pulmonary Fibrosis and Airway Stenosis.
- Genomic Profiles
- Anticoagulant Therapy
- Tracheostomy
- PD-1 and PD-L1
- Cardiac
- Airway Stenosis
- Fibrosis
- EGFR Mutations
- Targeted Therapy
- Clinical Trials
- ALK Inhibitors
- Diagnosis
- Idiopathic Pulmonary Fibrosis
- Antithrombotic Therapy
- Immune Checkpoint Blockade
- Sarcoidosis
- Venous Thromboembolism
- Atrial Fibrillation
- Small-Cell Lung Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Clinical Trials142 topics
- Targeted Therapy142 topics
- ALK Inhibitors111 topic
- EGFR Mutations111 topic
- Diagnosis82 topics
- Fibrosis71 topic
- Idiopathic Pulmonary Fibrosis71 topic
- Airway Stenosis41 topic
- Antithrombotic Therapy41 topic
- Cardiac41 topic
- Immune Checkpoint Blockade41 topic
- PD-1 and PD-L141 topic
- Sarcoidosis41 topic
- Tracheostomy41 topic
- Venous Thromboembolism41 topic
- Anticoagulant Therapy31 topic
- Atrial Fibrillation31 topic
- Genomic Profiles31 topic
- Small-Cell Lung Cancer31 topic
Where does Keita Kawakado work?
Keita Kawakado's main affiliation in the publication record is Iwakuni Medical Center, Japan.
How many publications and citations does Keita Kawakado have?
OpenAlex counts 30 works and 125 citations for Keita Kawakado, an h-index of 7, ranking #5,746,268 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Keita Kawakado. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.